- Home
- ZVRA vs CTO Comparison
ZVRA vs CTO Comparison
Compare ZVRA & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVRA | CTO |
|---|---|---|
| Founded | 2006 | 1902 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 653.2M | 599.1M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZVRA | CTO |
|---|---|---|
| Price | $11.13 | $19.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $23.00 | $22.50 |
| AVG Volume (30 Days) | ★ 1.1M | 245.4K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 7.44% |
| EPS Growth | ★ 159.21 | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $106,470,000.00 | N/A |
| Revenue This Year | $37.27 | $7.63 |
| Revenue Next Year | $53.42 | $2.76 |
| P/E Ratio | $18.52 | ★ N/A |
| Revenue Growth | ★ 350.91 | N/A |
| 52 Week Low | $7.16 | $15.07 |
| 52 Week High | $13.16 | $20.67 |
Technical Indicators
Market Signals| Indicator | ZVRA | CTO |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 49.56 |
| Support Level | $8.30 | $19.22 |
| Resistance Level | $12.14 | $20.08 |
| Average True Range (ATR) | 0.57 | 0.39 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 69.60 | 36.92 |
Price Performance
Historical ComparisonAbout ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.